Trivitron Group to set up Rs 250 cr medical technology park
Trivitron Group of Companies will establishment a Rs 250-cr Medical Technology Park at SIPCOT Industrial Park in Chennai.
By PTI |
CHENNAI: Medical technology products manufacturer Trivitron Group of Companies has announced the establishment of a Rs 250-crore Medical Technology Park at SIPCOT Industrial Park at Sriperumbudur near here, the foundation stone for which was laid on Monday.
The facility would be implemented by way of a joint venture with Japan-based Aloka Company Ltd, which is holding the major stakes at 60 per cent, Trivitron Group of Companies Managing Director GSK Velu told reporters here.
The company had also forged JVs with Biosystems of Spain and Brandon Medical of the UK and was holding major stakes of 60 per cent and 51 per cent respectively, he said.
Velu said that the park would come up on 23 acres of land, and added that the company proposed to acquire 2 more acres of land as it was exploring the possibility of converting the park into a Special Economic Zone (SEZ).
"Cost effective, high quality medical technology products will be manufactured here, with a view to export them to South Asia, Middle East and African markets, besides selling them in India," he said.
Manufacturing the products in India for domestic use would reduce their prices by 30-40 per cent, he claimed, adding that most of them were presently being imported.
He also said that the company planned to employ 3,000 persons in the next three years and said that the operations involving Aloka would start by next January, while those with Biosystems and Brandon would start by March 2009.
The facility would be implemented by way of a joint venture with Japan-based Aloka Company Ltd, which is holding the major stakes at 60 per cent, Trivitron Group of Companies Managing Director GSK Velu told reporters here.
The company had also forged JVs with Biosystems of Spain and Brandon Medical of the UK and was holding major stakes of 60 per cent and 51 per cent respectively, he said.
Velu said that the park would come up on 23 acres of land, and added that the company proposed to acquire 2 more acres of land as it was exploring the possibility of converting the park into a Special Economic Zone (SEZ).
"Cost effective, high quality medical technology products will be manufactured here, with a view to export them to South Asia, Middle East and African markets, besides selling them in India," he said.
Manufacturing the products in India for domestic use would reduce their prices by 30-40 per cent, he claimed, adding that most of them were presently being imported.
ADVERTISEMENT
He also said that the company planned to employ 3,000 persons in the next three years and said that the operations involving Aloka would start by next January, while those with Biosystems and Brandon would start by March 2009.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
